JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, Z.-W.
Right arrow Articles by Hoffman, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, Z.-W.
Right arrow Articles by Hoffman, B. B.

Vol. 303, Issue 2, 563-573, November 2002

Angiotensin II Increases Expression of Cyclooxygenase-2: Implications for the Function of Vascular Smooth Muscle Cells

Zhuo-Wei Hu , Reinhold Kerb1 , Xiao-You Shi , Tzuping Wei-Lavery and Brian B. Hoffman

Geriatric Research, Education, and Clinical Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, California (Z.-W.H., X.-Y.S., T.W.-L., B.B.H.), and the Department of Medicine, Stanford University School of Medicine, Stanford, California (Z.-W.H., R.K., X.-Y.S., T.W.-L., B.B.H.)

In vascular smooth muscle, increased expression of cyclooxygenase-2 (COX-2) has emerged as an important mechanism for regulation of prostanoid synthesis influenced by vessel injury, cytokines, and growth factors. We have investigated how COX-2 participates in angiotensin II (ANG II)-mediated cell responses in cultured human vascular smooth muscle cells (VSMCs). ANG II type 1 (AT1) receptors induce increased accumulation of COX-2, both at the mRNA and protein levels. ANG II increased transcription of the COX-2 gene; also, nuclear extracts from stimulated cells had increased NF-kappa B binding to its DNA consensus sequence. ANG II-induced COX-2 expression was markedly blunted by inhibition of mitogen-activated protein kinase. Furthermore, the ANG II-induced increase in COX-2 protein abundance was attenuated by both the peroxisome proliferator-activated receptor alpha  (PPARalpha ) activator Wy-14,643 [pyrinixic acid; 4-chloro-6-(2,3-xylidino)-2-pyrimidinyl) thioacetic acid] and the PPARgamma activator 15d-PGJ2 (15-deoxy-Delta 12-14-prostaglandin J2). Not only did ANG II increase COX-2 expression and prostaglandin synthesis, ANG II-stimulated DNA synthesis and cell migration were dependent on COX-2 activity. PPARalpha and PPARgamma activators inhibited ANG II-stimulated DNA synthesis and cell migration. These results suggest that ANG II enhances COX-2 expression at the transcription level; also, COX-2 activity plays an important role in mediating ANG II- induced proliferation and migration of VSMCs, suggesting the possibility of magnification of ANG II effects over time due to the induction of COX-2 expression. These results also demonstrate that both the alpha  and gamma  type of PPAR activators inhibit COX-2 expression induced by angiotensin II in VSMCs which may have therapeutic significance in vascular diseases.


1 Current address: Epidauros Biotechnologie AG, Munich, Germany.


0022-3565/02/3032-0563$00.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by U.S. Government



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Alvarez, J. V. Perez-Giron, R. Hernanz, A. M. Briones, A. Garcia-Redondo, A. Beltran, M. J. Alonso, and M. Salaices
Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive Rats
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 381 - 388.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. A. Morinelli, J. R. Raymond, A. Baldys, Q. Yang, M.-h. Lee, L. Luttrell, and M. E. Ullian
Identification of a putative nuclear localization sequence within ANG II AT1A receptor associated with nuclear activation
Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1398 - C1408.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Zahradka, B. Wright, M. Fuerst, N. Yurkova, K. Molnar, and C. G. Taylor
Peroxisome Proliferator-Activated Receptor {alpha} and {gamma} Ligands Differentially Affect Smooth Muscle Cell Proliferation and Migration
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 651 - 659.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. L. King, D. B. Trivedi, J. M. Gitlin, and C. D. Loftin
Selective Cyclooxygenase-2 Inhibition With Celecoxib Decreases Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1137 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Rodriguez, P. De la Cerda, E. Collyer, V. Decap, C. P. Vio, and V. Velarde
Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H30 - H36.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z. Guo, W. Su, S. Allen, H. Pang, A. Daugherty, E. Smart, and M. C. Gong
COX-2 Up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice
Cardiovasc Res, September 1, 2005; 67(4): 723 - 735.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. J.E. Sattler, J. E. Woodrum, O. Galili, M. Olson, S. Samee, F. B. Meyer, X.-Y. Zhu, L. O. Lerman, and A. Lerman
Concurrent Treatment With Renin-Angiotensin System Blockers and Acetylsalicylic Acid Reduces Nuclear Factor {kappa}B Activation and C-Reactive Protein Expression in Human Carotid Artery Plaques
Stroke, January 1, 2005; 36(1): 14 - 20.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. K. Whalin and W. R. Taylor
Rounding up the usual suspects in atherosclerosis. Focus on "Growth factors induce monocyte binding to vascular smooth muscle"
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C592 - C593.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Q. Cai, L. Lanting, and R. Natarajan
Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C707 - C714.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Drenjancevic-Peric and J. H. Lombard
Introgression of chromosome 13 in Dahl salt-sensitive genetic background restores cerebral vascular relaxation
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H957 - H962.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Wang, T. Chabrashvili, and C. S. Wilcox
Enhanced Contractility of Renal Afferent Arterioles From Angiotensin-Infused Rabbits: Roles of Oxidative Stress, Thromboxane Prostanoid Receptors, and Endothelium
Circ. Res., June 11, 2004; 94(11): 1436 - 1442.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Jiang, S. Xu, X. Hou, D. R. Pimentel, and R. A. Cohen
Angiotensin II Differentially Regulates Interleukin-1-{beta}-inducible NO Synthase (iNOS) and Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression: ROLE OF p38 MAPK
J. Biol. Chem., May 7, 2004; 279(19): 20363 - 20368.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Cipollone, B. Rocca, and C. Patrono
Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis
Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 246 - 255.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. Bregonzio, I. Armando, H. Ando, M. Jezova, G. Baiardi, and J. M. Saavedra
Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury
Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G414 - G423.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.